|
Bharat Book added a new report on " Pharmaceuticals report, “Syndax Pharmaceuticals, Inc. - Product Pipeline Review - Q2 2011” provides data on the Syndax Pharmaceuticals, Inc.’s research and development focus." Syndax Pharmaceuticals, Inc. - Product Pipeline Review The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Syndax Pharmaceuticals, Inc.’s corporate website, SEC filings, investor presentations and featured press releases, both from Syndax Pharmaceuticals, Inc. and industry-specific third party sources, put together by Global Markets Direct’s team. http://www.bharatbook.com/detail.asp?id=158676&rt=Syndax-Pharmaceuticals-Inc-Product-Pipeline-Review.html - Syndax Pharmaceuticals, Inc. - Brief Syndax Pharmaceuticals, Inc. overview including business description, key information and facts, and its locations and subsidiaries. - Review of current pipeline of Syndax Pharmaceuticals, Inc. human therapeutic division. - Overview of pipeline therapeutics across various therapy areas. - Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe. - Product profiles for late stage and clinical stage products of Syndax Pharmaceuticals, Inc. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones. - Recent updates of the Syndax Pharmaceuticals, Inc.’s pipeline in the last quarter. - Key discontinued and dormant projects. - Latest news and deals relating to the products. Reasons to buy - Evaluate Syndax Pharmaceuticals, Inc.’s strategic position with total access to detailed information on its product pipeline. - Assess the growth potential of Syndax Pharmaceuticals, Inc. in its therapy areas of focus. - Identify new drug targets and therapeutic classes in the Syndax Pharmaceuticals, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas. - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps. - Exploit collaboration and partnership opportunities with Syndax Pharmaceuticals, Inc.. - Avoid Intellectual Property Rights related issues. - Explore the dormant and discontinued projects of Syndax Pharmaceuticals, Inc. and identify potential opportunities in those areas. For more information kindly visit : http://www.bharatbook.com/detail.asp?id=158676&rt=Syndax-Pharmaceuticals-Inc-Product-Pipeline-Review.html Related Reports BioSante Pharmaceuticals Inc-Detailed Product Pipeline Or Contact us at : Bharat Book Bureau Tel: +91 22 27578668 Fax: +91 22 27579131 Email: info@bharatbook.com Website: www.bharatbook.com Follow us on twitter: http://twitter.com/#!/BharatBook
Related Articles -
Syndax Pharmaceuticals, Demand Forecast, Market, Market Forecast, Market Growth, Market Leaders.Research,
|
